Search for: "Does 1-37" Results 3821 - 3840 of 5,277
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
14 Nov 2011, 4:46 pm by FDABlog HPM
APP argues in its briefs (here and here) that there are two reasons why AIA Section 37 does not save MDCO’s PTE request for the ‘404 patent, but rather confirms that the PTE application was untimely, and that as such, the Federal Circuit should reverse Judge Hilton’s decision and deem the ‘404 patent to have expired as of March 23, 2010: (1) Section 37 will not go into effect until [September 16, 2012]. [read post]
14 Nov 2011, 9:09 am by Dennis Crouch
  Although participating in such activity violates the rules of conduct for patent law professionals under 37 C.F.R. 10.22, patent owners apparently will not face consequences. [read post]
10 Nov 2011, 7:00 am by Scott Van Soye
Available at SSRN.com (last visited 9/17/2011) 50 University of Nottingham “Saying sorry really does cost nothing. [read post]
10 Nov 2011, 6:15 am
Hispanic students received 37 percent of suspensions and they make up 40 percent of students. [read post]
7 Nov 2011, 10:43 am
Tennessee Code Annotated section 36-1-113(b) does not include the parent of a child as one of the persons or entities with standing to file a petition to terminate parental rights. [read post]
2 Nov 2011, 4:53 am
 While he's not quite fighting back the tears, he does rather feel that the High Court and the Court of Appeal were right and that it's the law that's wrong. [read post]
30 Oct 2011, 8:27 am by Steve Statsinger
Under this scenario, the the starting point would have been level 37, and a departure to 34 would produce a range of 262 to 327. [read post]
27 Oct 2011, 2:19 pm by PaulKostro
Eggleston, 37 N.J. 114, 131, 179 A.2d 505, 514 (1962). [read post]
26 Oct 2011, 2:30 am by Marie Louise
” – Cases G 2/07 and G 1/08 (IPKat) US: FDA proposes to clarify and update orphan drug regulations (FDA Law Blog) US: Sessions/Coburn Amendment to FDA Approps Bill seeks to effectively nullify AIA Section 37 ANGIOMAX PTE provision (FDA Law Blog) US: FTC Issues FY 2011 patent settlement report; attempts to keep up the heat on passage of the Preserve Access to Affordable Generics Act (FDA Law Blog) US: The FTC’s thinking does not make it so regarding… [read post]